Allgemein

First Conference “Advancements in Animal-Free Research and Translational Medicine” in Munich

PELOBIOTECH GmbH is happy to announce organizing the first conference "Advancements in Animal-Free Research and Translational Medicine" in Munich/Gräfelfing. Scheduled for June 27, 2024, this conference aims to spotlight novel non-animal approaches vital for progress in translational medical research. The Munich Cell Specialist PELOBIOTECH distributes one of the broadest portfolios of 2D&3D cell culture systems, cell culture products and media.

The conference will start with an overview of the development and validation of serum substitutes. “Paving the way for ethically sound alternatives is crucial today for scientific advancements”, said Dr. Lothar Steeb, Co-CEO&CSO PELOBiotech. In addition to getting insights on the principles of cell culture and stem cells, presentations will focus on applications and hands-on experiences in the lab. “We are happy to have gained so many experts from the scientific community to offer a great networking opportunity beyond their research fields”, said Dr. Peter Frost, CEO PELOBIOTECH GmbH.

The focus is on networking and collaboration between scientists and experts in the field. An organized face-to-face lunch and breaks with the speakers will provide ample time for an exchange of views and further questions. A panel discussion with concluding remarks and a toast at the rooftop bar will provide an opportunity to ask for final follow-ups.

Attendees can expect an overview of numerous innovative applications throughout the day. Highlighted topics include serum-free media and  serum alternatives, the translational applicability of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) in therapeutic contexts, the utilization of human adipocyte spheroids for obesity research, and the scalability of cardiac organoids for preclinical applications in cardiovascular research and pharmacology.

PELOBIOTECH’s CEOs, Dr. Peter Frost and Dr. Lothar Steeb, will kick off the conference, followed by presentations from speakers such as

  • Prof. Dr. Gerhard Gstraunthaler, Institut für Physiologie der Medizinischen Universität Innsbruck, emer
  • Prof. Dr. rer. nat. Bernd Giebel, Institut für Transfusionsmedizin, Universitätsklinikum Essen
  • PD Dr. Kurt Pfannkuche, Faculty of Medicine, Universität zu Köln
  • Dr. rer. nat. Anita Wagner, Lehrstuhl für Molekulare Ernährungsmedizin, Technische Universität München (TUM)
  • Dr. Flavia Rezende, Center for Molecular Medicine, Goethe-Universität Frankfurt
  • Dr. Raquel Sousa, abc biopply, Cham, Switzerland

Discussions will extend to include classic 2D cell culture to 3D humanized multi-organoid systems for disease modeling and pharmacodynamics, illustrating their potential for simulating complex disease states and therapeutic interventions. For more details go to https://www.pelobiotech.com/resources/conferences.html

Conference Details:

Über die PELOBIOTECH GmbH

PELOBIOTECH GmbH is based in Planegg (Munich area), Germany, and is a leading distributor of high-quality and innovative life science research tools and reagents with a focus on 2D/3D cell culture. With over 18,000 products it has one of the worldwide broadest portfolios of primary cell and stem cell biology solutions.

With its worldwide network of innovative and highly specialized companies, PELOBiotech is a scientist’s first place to go.
Pick the right tools:

– Human/Animal Primary and Stem Cells
corresponding media, also defined or xeno-free media
-ES/iPS Cells, Media, & Tools
– modified (KD/KO) or labeled Primary/Stem cells
– Customized Tissue Sourcing & Cell Isolation
– Cell Culture Tools
– 3D Cell Culture technologies and models easy-to-use & Tools
– 3D-micro tissue ready-to-use
– Biomatrix (ECM), Organospeciific ECM, Smart Hydrogels
– Reprogramming Tools & Small Molecules
– Angiogenese-Modelle
– MicroMatrix-Test
– Cell Culture Tools: Recombinant Proteins like Cytokines, Growth factors
Antibodies,
– Midifluidic chambers, Microfluidic Chips
– High-performance microsphere products
– Premium Grade & GMP
– Cell-based assays
– Cold- and Cryo-preservation media

Firmenkontakt und Herausgeber der Meldung:

PELOBIOTECH GmbH
Behringstrasse 10
82152 Planegg/Martinsried
Telefon: +49 (89) 51777140
Telefax: +49 (89) 51777160
http://www.pelobiotech.com

Ansprechpartner:
Christiane Büchsel
Marketing & Communications
Telefon: +49 (89) 51728659-11
E-Mail: christiane.buechsel@pelobiotech.com
Dr. Peter Frost
Telefon: +49 (89) 51777140
Fax: +49 (89) 51777160
E-Mail: peter.frost@pelobiotech.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel